Global Prostate Cancer Nuclear Medicine Diagnostics Market Research Report 2026(Status and Outlook)
Nuclear medicine, a type of imaging that uses radioactive materials, is a useful tool to detect and also treat prostate cancer. It is a form of diagnostic imaging that helps radiologists determine the stage of cancer.According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The global Prostate Cancer Nuclear Medicine Diagnostics market size was estimated at USD 868.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Prostate Cancer Nuclear Medicine Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Prostate Cancer Nuclear Medicine Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Prostate Cancer Nuclear Medicine Diagnostics market.
Global Prostate Cancer Nuclear Medicine Diagnostics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Blue Earth Diagnostics
PETNET Solutions
Cardinal Health
Lantheus Medical Imaging
Jubilant Pharma
NCM-USA
Progenics Pharma
Telix Pharma
ImaginAb
Theragnostics
Novartis
Alliance Medical
Market Segmentation (by Type)
SPECT
PET
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Prostate Cancer Nuclear Medicine Diagnostics Market
Overview of the regional outlook of the Prostate Cancer Nuclear Medicine Diagnostics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Prostate Cancer Nuclear Medicine Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Prostate Cancer Nuclear Medicine Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Prostate Cancer Nuclear Medicine Diagnostics market size was estimated at USD 868.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Prostate Cancer Nuclear Medicine Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Prostate Cancer Nuclear Medicine Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Prostate Cancer Nuclear Medicine Diagnostics market.
Global Prostate Cancer Nuclear Medicine Diagnostics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Blue Earth Diagnostics
PETNET Solutions
Cardinal Health
Lantheus Medical Imaging
Jubilant Pharma
NCM-USA
Progenics Pharma
Telix Pharma
ImaginAb
Theragnostics
Novartis
Alliance Medical
Market Segmentation (by Type)
SPECT
PET
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Prostate Cancer Nuclear Medicine Diagnostics Market
Overview of the regional outlook of the Prostate Cancer Nuclear Medicine Diagnostics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Prostate Cancer Nuclear Medicine Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Prostate Cancer Nuclear Medicine Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Prostate Cancer Nuclear Medicine Diagnostics
1.2 Key Market Segments
1.2.1 Prostate Cancer Nuclear Medicine Diagnostics Segment by Type
1.2.2 Prostate Cancer Nuclear Medicine Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Prostate Cancer Nuclear Medicine Diagnostics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Prostate Cancer Nuclear Medicine Diagnostics Product Life Cycle
3.3 Global Prostate Cancer Nuclear Medicine Diagnostics Sales by Manufacturers (2020-2025)
3.4 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Manufacturers (2020-2025)
3.5 Prostate Cancer Nuclear Medicine Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Prostate Cancer Nuclear Medicine Diagnostics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Prostate Cancer Nuclear Medicine Diagnostics Market Competitive Situation and Trends
3.8.1 Prostate Cancer Nuclear Medicine Diagnostics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Prostate Cancer Nuclear Medicine Diagnostics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Prostate Cancer Nuclear Medicine Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Prostate Cancer Nuclear Medicine Diagnostics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Prostate Cancer Nuclear Medicine Diagnostics Market
5.7 ESG Ratings of Leading Companies
6 PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Type (2020-2025)
6.3 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2020-2025)
6.4 Global Prostate Cancer Nuclear Medicine Diagnostics Price by Type (2020-2025)
7 PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Sales by Application (2020-2025)
7.3 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size (M USD) by Application (2020-2025)
7.4 Global Prostate Cancer Nuclear Medicine Diagnostics Sales Growth Rate by Application (2020-2025)
8 PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET SALES BY REGION
8.1 Global Prostate Cancer Nuclear Medicine Diagnostics Sales by Region
8.1.1 Global Prostate Cancer Nuclear Medicine Diagnostics Sales by Region
8.1.2 Global Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Region
8.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region
8.2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region
8.2.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region
8.3 North America
8.3.1 North America Prostate Cancer Nuclear Medicine Diagnostics Sales by Country
8.3.2 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Prostate Cancer Nuclear Medicine Diagnostics Sales by Country
8.4.2 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Sales by Region
8.5.2 Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Prostate Cancer Nuclear Medicine Diagnostics Sales by Country
8.6.2 South America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Sales by Region
8.7.2 Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Prostate Cancer Nuclear Medicine Diagnostics by Region(2020-2025)
9.2 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Region (2020-2025)
9.3 Global Prostate Cancer Nuclear Medicine Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Prostate Cancer Nuclear Medicine Diagnostics Production
9.4.1 North America Prostate Cancer Nuclear Medicine Diagnostics Production Growth Rate (2020-2025)
9.4.2 North America Prostate Cancer Nuclear Medicine Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Prostate Cancer Nuclear Medicine Diagnostics Production
9.5.1 Europe Prostate Cancer Nuclear Medicine Diagnostics Production Growth Rate (2020-2025)
9.5.2 Europe Prostate Cancer Nuclear Medicine Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Prostate Cancer Nuclear Medicine Diagnostics Production (2020-2025)
9.6.1 Japan Prostate Cancer Nuclear Medicine Diagnostics Production Growth Rate (2020-2025)
9.6.2 Japan Prostate Cancer Nuclear Medicine Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Prostate Cancer Nuclear Medicine Diagnostics Production (2020-2025)
9.7.1 China Prostate Cancer Nuclear Medicine Diagnostics Production Growth Rate (2020-2025)
9.7.2 China Prostate Cancer Nuclear Medicine Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Blue Earth Diagnostics
10.1.1 Blue Earth Diagnostics Basic Information
10.1.2 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.1.3 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.1.4 Blue Earth Diagnostics Business Overview
10.1.5 Blue Earth Diagnostics SWOT Analysis
10.1.6 Blue Earth Diagnostics Recent Developments
10.2 PETNET Solutions
10.2.1 PETNET Solutions Basic Information
10.2.2 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.2.3 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.2.4 PETNET Solutions Business Overview
10.2.5 PETNET Solutions SWOT Analysis
10.2.6 PETNET Solutions Recent Developments
10.3 Cardinal Health
10.3.1 Cardinal Health Basic Information
10.3.2 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.3.3 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.3.4 Cardinal Health Business Overview
10.3.5 Cardinal Health SWOT Analysis
10.3.6 Cardinal Health Recent Developments
10.4 Lantheus Medical Imaging
10.4.1 Lantheus Medical Imaging Basic Information
10.4.2 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.4.3 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.4.4 Lantheus Medical Imaging Business Overview
10.4.5 Lantheus Medical Imaging Recent Developments
10.5 Jubilant Pharma
10.5.1 Jubilant Pharma Basic Information
10.5.2 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.5.3 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.5.4 Jubilant Pharma Business Overview
10.5.5 Jubilant Pharma Recent Developments
10.6 NCM-USA
10.6.1 NCM-USA Basic Information
10.6.2 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.6.3 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.6.4 NCM-USA Business Overview
10.6.5 NCM-USA Recent Developments
10.7 Progenics Pharma
10.7.1 Progenics Pharma Basic Information
10.7.2 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.7.3 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.7.4 Progenics Pharma Business Overview
10.7.5 Progenics Pharma Recent Developments
10.8 Telix Pharma
10.8.1 Telix Pharma Basic Information
10.8.2 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.8.3 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.8.4 Telix Pharma Business Overview
10.8.5 Telix Pharma Recent Developments
10.9 ImaginAb
10.9.1 ImaginAb Basic Information
10.9.2 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.9.3 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.9.4 ImaginAb Business Overview
10.9.5 ImaginAb Recent Developments
10.10 Theragnostics
10.10.1 Theragnostics Basic Information
10.10.2 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.10.3 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.10.4 Theragnostics Business Overview
10.10.5 Theragnostics Recent Developments
10.11 Novartis
10.11.1 Novartis Basic Information
10.11.2 Novartis Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.11.3 Novartis Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.11.4 Novartis Business Overview
10.11.5 Novartis Recent Developments
10.12 Alliance Medical
10.12.1 Alliance Medical Basic Information
10.12.2 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.12.3 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.12.4 Alliance Medical Business Overview
10.12.5 Alliance Medical Recent Developments
11 PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET FORECAST BY REGION
11.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast
11.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Region
11.2.4 South America Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Prostate Cancer Nuclear Medicine Diagnostics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Prostate Cancer Nuclear Medicine Diagnostics by Type (2026-2035)
12.1.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Prostate Cancer Nuclear Medicine Diagnostics by Type (2026-2035)
12.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Forecast by Application (2026-2035)
12.2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT) Forecast by Application
12.2.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Prostate Cancer Nuclear Medicine Diagnostics
1.2 Key Market Segments
1.2.1 Prostate Cancer Nuclear Medicine Diagnostics Segment by Type
1.2.2 Prostate Cancer Nuclear Medicine Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Prostate Cancer Nuclear Medicine Diagnostics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Prostate Cancer Nuclear Medicine Diagnostics Product Life Cycle
3.3 Global Prostate Cancer Nuclear Medicine Diagnostics Sales by Manufacturers (2020-2025)
3.4 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Manufacturers (2020-2025)
3.5 Prostate Cancer Nuclear Medicine Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Prostate Cancer Nuclear Medicine Diagnostics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Prostate Cancer Nuclear Medicine Diagnostics Market Competitive Situation and Trends
3.8.1 Prostate Cancer Nuclear Medicine Diagnostics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Prostate Cancer Nuclear Medicine Diagnostics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Prostate Cancer Nuclear Medicine Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Prostate Cancer Nuclear Medicine Diagnostics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Prostate Cancer Nuclear Medicine Diagnostics Market
5.7 ESG Ratings of Leading Companies
6 PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Type (2020-2025)
6.3 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2020-2025)
6.4 Global Prostate Cancer Nuclear Medicine Diagnostics Price by Type (2020-2025)
7 PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Sales by Application (2020-2025)
7.3 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size (M USD) by Application (2020-2025)
7.4 Global Prostate Cancer Nuclear Medicine Diagnostics Sales Growth Rate by Application (2020-2025)
8 PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET SALES BY REGION
8.1 Global Prostate Cancer Nuclear Medicine Diagnostics Sales by Region
8.1.1 Global Prostate Cancer Nuclear Medicine Diagnostics Sales by Region
8.1.2 Global Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Region
8.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region
8.2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region
8.2.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region
8.3 North America
8.3.1 North America Prostate Cancer Nuclear Medicine Diagnostics Sales by Country
8.3.2 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Prostate Cancer Nuclear Medicine Diagnostics Sales by Country
8.4.2 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Sales by Region
8.5.2 Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Prostate Cancer Nuclear Medicine Diagnostics Sales by Country
8.6.2 South America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Sales by Region
8.7.2 Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Prostate Cancer Nuclear Medicine Diagnostics by Region(2020-2025)
9.2 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Region (2020-2025)
9.3 Global Prostate Cancer Nuclear Medicine Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Prostate Cancer Nuclear Medicine Diagnostics Production
9.4.1 North America Prostate Cancer Nuclear Medicine Diagnostics Production Growth Rate (2020-2025)
9.4.2 North America Prostate Cancer Nuclear Medicine Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Prostate Cancer Nuclear Medicine Diagnostics Production
9.5.1 Europe Prostate Cancer Nuclear Medicine Diagnostics Production Growth Rate (2020-2025)
9.5.2 Europe Prostate Cancer Nuclear Medicine Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Prostate Cancer Nuclear Medicine Diagnostics Production (2020-2025)
9.6.1 Japan Prostate Cancer Nuclear Medicine Diagnostics Production Growth Rate (2020-2025)
9.6.2 Japan Prostate Cancer Nuclear Medicine Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Prostate Cancer Nuclear Medicine Diagnostics Production (2020-2025)
9.7.1 China Prostate Cancer Nuclear Medicine Diagnostics Production Growth Rate (2020-2025)
9.7.2 China Prostate Cancer Nuclear Medicine Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Blue Earth Diagnostics
10.1.1 Blue Earth Diagnostics Basic Information
10.1.2 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.1.3 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.1.4 Blue Earth Diagnostics Business Overview
10.1.5 Blue Earth Diagnostics SWOT Analysis
10.1.6 Blue Earth Diagnostics Recent Developments
10.2 PETNET Solutions
10.2.1 PETNET Solutions Basic Information
10.2.2 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.2.3 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.2.4 PETNET Solutions Business Overview
10.2.5 PETNET Solutions SWOT Analysis
10.2.6 PETNET Solutions Recent Developments
10.3 Cardinal Health
10.3.1 Cardinal Health Basic Information
10.3.2 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.3.3 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.3.4 Cardinal Health Business Overview
10.3.5 Cardinal Health SWOT Analysis
10.3.6 Cardinal Health Recent Developments
10.4 Lantheus Medical Imaging
10.4.1 Lantheus Medical Imaging Basic Information
10.4.2 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.4.3 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.4.4 Lantheus Medical Imaging Business Overview
10.4.5 Lantheus Medical Imaging Recent Developments
10.5 Jubilant Pharma
10.5.1 Jubilant Pharma Basic Information
10.5.2 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.5.3 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.5.4 Jubilant Pharma Business Overview
10.5.5 Jubilant Pharma Recent Developments
10.6 NCM-USA
10.6.1 NCM-USA Basic Information
10.6.2 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.6.3 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.6.4 NCM-USA Business Overview
10.6.5 NCM-USA Recent Developments
10.7 Progenics Pharma
10.7.1 Progenics Pharma Basic Information
10.7.2 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.7.3 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.7.4 Progenics Pharma Business Overview
10.7.5 Progenics Pharma Recent Developments
10.8 Telix Pharma
10.8.1 Telix Pharma Basic Information
10.8.2 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.8.3 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.8.4 Telix Pharma Business Overview
10.8.5 Telix Pharma Recent Developments
10.9 ImaginAb
10.9.1 ImaginAb Basic Information
10.9.2 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.9.3 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.9.4 ImaginAb Business Overview
10.9.5 ImaginAb Recent Developments
10.10 Theragnostics
10.10.1 Theragnostics Basic Information
10.10.2 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.10.3 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.10.4 Theragnostics Business Overview
10.10.5 Theragnostics Recent Developments
10.11 Novartis
10.11.1 Novartis Basic Information
10.11.2 Novartis Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.11.3 Novartis Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.11.4 Novartis Business Overview
10.11.5 Novartis Recent Developments
10.12 Alliance Medical
10.12.1 Alliance Medical Basic Information
10.12.2 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Product Overview
10.12.3 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Product Market Performance
10.12.4 Alliance Medical Business Overview
10.12.5 Alliance Medical Recent Developments
11 PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET FORECAST BY REGION
11.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast
11.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Region
11.2.4 South America Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Prostate Cancer Nuclear Medicine Diagnostics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Prostate Cancer Nuclear Medicine Diagnostics by Type (2026-2035)
12.1.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Prostate Cancer Nuclear Medicine Diagnostics by Type (2026-2035)
12.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Forecast by Application (2026-2035)
12.2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT) Forecast by Application
12.2.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (M USD)
Table 4. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application
Table 5. Prostate Cancer Nuclear Medicine Diagnostics Market Size Comparison by Region (M USD)
Table 6. Global Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Nuclear Medicine Diagnostics as of 2025)
Table 11. Global Market Prostate Cancer Nuclear Medicine Diagnostics Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Prostate Cancer Nuclear Medicine Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Prostate Cancer Nuclear Medicine Diagnostics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Prostate Cancer Nuclear Medicine Diagnostics Sales by Type (K MT)
Table 27. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (M USD)
Table 28. Global Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT) by Type (2020-2025)
Table 29. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Type (2020-2025)
Table 30. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size (M USD) by Type (2020-2025)
Table 31. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type (2020-2025)
Table 32. Global Prostate Cancer Nuclear Medicine Diagnostics Price (USD/KG) by Type (2020-2025)
Table 33. Global Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT) by Application
Table 34. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application
Table 35. Global Prostate Cancer Nuclear Medicine Diagnostics Sales by Application (2020-2025) & (K MT)
Table 36. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Application (2020-2025)
Table 37. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application (2020-2025)
Table 39. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Growth Rate by Application (2020-2025)
Table 40. Global Prostate Cancer Nuclear Medicine Diagnostics Sales by Region (2020-2025) & (K MT)
Table 41. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Region (2020-2025)
Table 42. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2020-2025)
Table 44. North America Prostate Cancer Nuclear Medicine Diagnostics Sales by Country (2020-2025) & (K MT)
Table 45. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Prostate Cancer Nuclear Medicine Diagnostics Sales by Country (2020-2025) & (K MT)
Table 47. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Prostate Cancer Nuclear Medicine Diagnostics Sales by Country (2020-2025) & (K MT)
Table 51. South America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Prostate Cancer Nuclear Medicine Diagnostics Production (K MT) by Region(2020-2025)
Table 55. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Region (2020-2025)
Table 57. Global Prostate Cancer Nuclear Medicine Diagnostics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Prostate Cancer Nuclear Medicine Diagnostics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Prostate Cancer Nuclear Medicine Diagnostics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Prostate Cancer Nuclear Medicine Diagnostics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Prostate Cancer Nuclear Medicine Diagnostics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Blue Earth Diagnostics Basic Information
Table 63. Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 64. Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Blue Earth Diagnostics Business Overview
Table 66. Blue Earth Diagnostics SWOT Analysis
Table 67. Blue Earth Diagnostics Recent Developments
Table 68. PETNET Solutions Basic Information
Table 69. PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 70. PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. PETNET Solutions Business Overview
Table 72. PETNET Solutions SWOT Analysis
Table 73. PETNET Solutions Recent Developments
Table 74. Cardinal Health Basic Information
Table 75. Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 76. Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Cardinal Health Business Overview
Table 78. Cardinal Health SWOT Analysis
Table 79. Cardinal Health Recent Developments
Table 80. Lantheus Medical Imaging Basic Information
Table 81. Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 82. Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Lantheus Medical Imaging Business Overview
Table 84. Lantheus Medical Imaging Recent Developments
Table 85. Jubilant Pharma Basic Information
Table 86. Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 87. Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Jubilant Pharma Business Overview
Table 89. Jubilant Pharma Recent Developments
Table 90. NCM-USA Basic Information
Table 91. NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 92. NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. NCM-USA Business Overview
Table 94. NCM-USA Recent Developments
Table 95. Progenics Pharma Basic Information
Table 96. Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 97. Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Progenics Pharma Business Overview
Table 99. Progenics Pharma Recent Developments
Table 100. Telix Pharma Basic Information
Table 101. Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 102. Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Telix Pharma Business Overview
Table 104. Telix Pharma Recent Developments
Table 105. ImaginAb Basic Information
Table 106. ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 107. ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. ImaginAb Business Overview
Table 109. ImaginAb Recent Developments
Table 110. Theragnostics Basic Information
Table 111. Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 112. Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Theragnostics Business Overview
Table 114. Theragnostics Recent Developments
Table 115. Novartis Basic Information
Table 116. Novartis Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 117. Novartis Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Novartis Business Overview
Table 119. Novartis Recent Developments
Table 120. Alliance Medical Basic Information
Table 121. Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 122. Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Alliance Medical Business Overview
Table 124. Alliance Medical Recent Developments
Table 125. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Forecast by Region (2026-2035) & (K MT)
Table 126. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Prostate Cancer Nuclear Medicine Diagnostics Sales Forecast by Country (2026-2035) & (K MT)
Table 128. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Prostate Cancer Nuclear Medicine Diagnostics Sales Forecast by Country (2026-2035) & (K MT)
Table 130. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Sales Forecast by Region (2026-2035) & (K MT)
Table 132. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Prostate Cancer Nuclear Medicine Diagnostics Sales Forecast by Country (2026-2035) & (K MT)
Table 134. South America Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Forecast by Type (2026-2035) & (K MT)
Table 138. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Prostate Cancer Nuclear Medicine Diagnostics Price Forecast by Type (2026-2035) & (USD/KG)
Table 140. Global Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT) Forecast by Application (2026-2035)
Table 141. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (M USD)
Table 4. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application
Table 5. Prostate Cancer Nuclear Medicine Diagnostics Market Size Comparison by Region (M USD)
Table 6. Global Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Nuclear Medicine Diagnostics as of 2025)
Table 11. Global Market Prostate Cancer Nuclear Medicine Diagnostics Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Prostate Cancer Nuclear Medicine Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Prostate Cancer Nuclear Medicine Diagnostics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Prostate Cancer Nuclear Medicine Diagnostics Sales by Type (K MT)
Table 27. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (M USD)
Table 28. Global Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT) by Type (2020-2025)
Table 29. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Type (2020-2025)
Table 30. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size (M USD) by Type (2020-2025)
Table 31. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type (2020-2025)
Table 32. Global Prostate Cancer Nuclear Medicine Diagnostics Price (USD/KG) by Type (2020-2025)
Table 33. Global Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT) by Application
Table 34. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application
Table 35. Global Prostate Cancer Nuclear Medicine Diagnostics Sales by Application (2020-2025) & (K MT)
Table 36. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Application (2020-2025)
Table 37. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application (2020-2025)
Table 39. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Growth Rate by Application (2020-2025)
Table 40. Global Prostate Cancer Nuclear Medicine Diagnostics Sales by Region (2020-2025) & (K MT)
Table 41. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Region (2020-2025)
Table 42. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2020-2025)
Table 44. North America Prostate Cancer Nuclear Medicine Diagnostics Sales by Country (2020-2025) & (K MT)
Table 45. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Prostate Cancer Nuclear Medicine Diagnostics Sales by Country (2020-2025) & (K MT)
Table 47. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Prostate Cancer Nuclear Medicine Diagnostics Sales by Country (2020-2025) & (K MT)
Table 51. South America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Prostate Cancer Nuclear Medicine Diagnostics Production (K MT) by Region(2020-2025)
Table 55. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Region (2020-2025)
Table 57. Global Prostate Cancer Nuclear Medicine Diagnostics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Prostate Cancer Nuclear Medicine Diagnostics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Prostate Cancer Nuclear Medicine Diagnostics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Prostate Cancer Nuclear Medicine Diagnostics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Prostate Cancer Nuclear Medicine Diagnostics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Blue Earth Diagnostics Basic Information
Table 63. Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 64. Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Blue Earth Diagnostics Business Overview
Table 66. Blue Earth Diagnostics SWOT Analysis
Table 67. Blue Earth Diagnostics Recent Developments
Table 68. PETNET Solutions Basic Information
Table 69. PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 70. PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. PETNET Solutions Business Overview
Table 72. PETNET Solutions SWOT Analysis
Table 73. PETNET Solutions Recent Developments
Table 74. Cardinal Health Basic Information
Table 75. Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 76. Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Cardinal Health Business Overview
Table 78. Cardinal Health SWOT Analysis
Table 79. Cardinal Health Recent Developments
Table 80. Lantheus Medical Imaging Basic Information
Table 81. Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 82. Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Lantheus Medical Imaging Business Overview
Table 84. Lantheus Medical Imaging Recent Developments
Table 85. Jubilant Pharma Basic Information
Table 86. Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 87. Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Jubilant Pharma Business Overview
Table 89. Jubilant Pharma Recent Developments
Table 90. NCM-USA Basic Information
Table 91. NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 92. NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. NCM-USA Business Overview
Table 94. NCM-USA Recent Developments
Table 95. Progenics Pharma Basic Information
Table 96. Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 97. Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Progenics Pharma Business Overview
Table 99. Progenics Pharma Recent Developments
Table 100. Telix Pharma Basic Information
Table 101. Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 102. Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Telix Pharma Business Overview
Table 104. Telix Pharma Recent Developments
Table 105. ImaginAb Basic Information
Table 106. ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 107. ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. ImaginAb Business Overview
Table 109. ImaginAb Recent Developments
Table 110. Theragnostics Basic Information
Table 111. Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 112. Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Theragnostics Business Overview
Table 114. Theragnostics Recent Developments
Table 115. Novartis Basic Information
Table 116. Novartis Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 117. Novartis Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Novartis Business Overview
Table 119. Novartis Recent Developments
Table 120. Alliance Medical Basic Information
Table 121. Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Product Overview
Table 122. Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Alliance Medical Business Overview
Table 124. Alliance Medical Recent Developments
Table 125. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Forecast by Region (2026-2035) & (K MT)
Table 126. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Prostate Cancer Nuclear Medicine Diagnostics Sales Forecast by Country (2026-2035) & (K MT)
Table 128. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Prostate Cancer Nuclear Medicine Diagnostics Sales Forecast by Country (2026-2035) & (K MT)
Table 130. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Sales Forecast by Region (2026-2035) & (K MT)
Table 132. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Prostate Cancer Nuclear Medicine Diagnostics Sales Forecast by Country (2026-2035) & (K MT)
Table 134. South America Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Forecast by Type (2026-2035) & (K MT)
Table 138. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Prostate Cancer Nuclear Medicine Diagnostics Price Forecast by Type (2026-2035) & (USD/KG)
Table 140. Global Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT) Forecast by Application (2026-2035)
Table 141. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Prostate Cancer Nuclear Medicine Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size (M USD), 2025-2035
Figure 5. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size (M USD) (2020-2035)
Figure 6. Global Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Prostate Cancer Nuclear Medicine Diagnostics Product Life Cycle
Figure 13. Prostate Cancer Nuclear Medicine Diagnostics Sales Share by Manufacturers in 2025
Figure 14. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Share by Manufacturers in 2025
Figure 15. Prostate Cancer Nuclear Medicine Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Prostate Cancer Nuclear Medicine Diagnostics Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Prostate Cancer Nuclear Medicine Diagnostics Revenue in 2025
Figure 18. Industry Chain Map of Prostate Cancer Nuclear Medicine Diagnostics
Figure 19. Global Prostate Cancer Nuclear Medicine Diagnostics Market PEST Analysis
Figure 20. Global Prostate Cancer Nuclear Medicine Diagnostics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type
Figure 27. Sales Market Share of Prostate Cancer Nuclear Medicine Diagnostics by Type (2020-2025)
Figure 28. Sales Market Share of Prostate Cancer Nuclear Medicine Diagnostics by Type in 2025
Figure 29. Market Share of Prostate Cancer Nuclear Medicine Diagnostics by Type (2020-2025)
Figure 30. Market Share of Prostate Cancer Nuclear Medicine Diagnostics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application
Figure 33. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Application (2020-2025)
Figure 34. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Application in 2025
Figure 35. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application (2020-2025)
Figure 36. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application in 2025
Figure 37. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Region (2020-2025)
Figure 39. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2020-2025)
Figure 40. North America Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Country in 2024
Figure 43. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country in 2024
Figure 45. U.S. Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Prostate Cancer Nuclear Medicine Diagnostics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Prostate Cancer Nuclear Medicine Diagnostics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Prostate Cancer Nuclear Medicine Diagnostics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Country in 2024
Figure 53. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country in 2024
Figure 55. Germany Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region in 2024
Figure 68. China Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (K MT)
Figure 79. South America Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Country in 2024
Figure 80. South America Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (M USD)
Figure 81. South America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country in 2024
Figure 82. Brazil Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region in 2024
Figure 92. Saudi Arabia Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Prostate Cancer Nuclear Medicine Diagnostics Production Market Share by Region (2020-2025)
Figure 103. North America Prostate Cancer Nuclear Medicine Diagnostics Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Prostate Cancer Nuclear Medicine Diagnostics Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Prostate Cancer Nuclear Medicine Diagnostics Production (K MT) Growth Rate (2020-2025)
Figure 106. China Prostate Cancer Nuclear Medicine Diagnostics Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share Forecast by Type (2026-2035)
Figure 111. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Forecast by Application (2026-2035)
Figure 112. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Prostate Cancer Nuclear Medicine Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size (M USD), 2025-2035
Figure 5. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size (M USD) (2020-2035)
Figure 6. Global Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Prostate Cancer Nuclear Medicine Diagnostics Product Life Cycle
Figure 13. Prostate Cancer Nuclear Medicine Diagnostics Sales Share by Manufacturers in 2025
Figure 14. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Share by Manufacturers in 2025
Figure 15. Prostate Cancer Nuclear Medicine Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Prostate Cancer Nuclear Medicine Diagnostics Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Prostate Cancer Nuclear Medicine Diagnostics Revenue in 2025
Figure 18. Industry Chain Map of Prostate Cancer Nuclear Medicine Diagnostics
Figure 19. Global Prostate Cancer Nuclear Medicine Diagnostics Market PEST Analysis
Figure 20. Global Prostate Cancer Nuclear Medicine Diagnostics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type
Figure 27. Sales Market Share of Prostate Cancer Nuclear Medicine Diagnostics by Type (2020-2025)
Figure 28. Sales Market Share of Prostate Cancer Nuclear Medicine Diagnostics by Type in 2025
Figure 29. Market Share of Prostate Cancer Nuclear Medicine Diagnostics by Type (2020-2025)
Figure 30. Market Share of Prostate Cancer Nuclear Medicine Diagnostics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application
Figure 33. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Application (2020-2025)
Figure 34. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Application in 2025
Figure 35. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application (2020-2025)
Figure 36. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application in 2025
Figure 37. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Region (2020-2025)
Figure 39. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2020-2025)
Figure 40. North America Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Country in 2024
Figure 43. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country in 2024
Figure 45. U.S. Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Prostate Cancer Nuclear Medicine Diagnostics Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Prostate Cancer Nuclear Medicine Diagnostics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Prostate Cancer Nuclear Medicine Diagnostics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Prostate Cancer Nuclear Medicine Diagnostics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Country in 2024
Figure 53. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country in 2024
Figure 55. Germany Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region in 2024
Figure 68. China Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (K MT)
Figure 79. South America Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Country in 2024
Figure 80. South America Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (M USD)
Figure 81. South America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country in 2024
Figure 82. Brazil Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region in 2024
Figure 92. Saudi Arabia Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Prostate Cancer Nuclear Medicine Diagnostics Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Prostate Cancer Nuclear Medicine Diagnostics Production Market Share by Region (2020-2025)
Figure 103. North America Prostate Cancer Nuclear Medicine Diagnostics Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Prostate Cancer Nuclear Medicine Diagnostics Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Prostate Cancer Nuclear Medicine Diagnostics Production (K MT) Growth Rate (2020-2025)
Figure 106. China Prostate Cancer Nuclear Medicine Diagnostics Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share Forecast by Type (2026-2035)
Figure 111. Global Prostate Cancer Nuclear Medicine Diagnostics Sales Forecast by Application (2026-2035)
Figure 112. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share Forecast by Application (2026-2035)
